Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Jul
21
Today In Oncology
Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes
Long-Term Outcomes With SABR in Primary Kidney Cancer
Long-Term Follow-up of Postoperative Chemoradiotherapy With Weekly vs Every-3-Week Cisplatin in Head and Neck Cancer
EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma
Mutant KRAS Vaccine for Prevention of Pancreatic Cancer Development Shows Durable Immune Responses
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo